Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide

Journal of Clinical Biochemistry and Nutrition

Volumn 43, Issue 3, 2008, Pages 139-142

  Inoue, Ken Ichiro ^a   Takano, Hirohisa ^a   Yanagisawa, Rie ^a   Yoshikawa, Toshikazu ^b  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cytokine; Fibrinogen; Lipopolysaccharide; Urinary trypsin inhibitor

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; ULINASTATIN;

ACUTE LUNG INJURY; ANTIINFLAMMATORY ACTIVITY; DRUG EFFECT; HISTOPATHOLOGY; MULTIPLE ORGAN FAILURE; NONHUMAN; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIA (MICROORGANISMS); MUS;

EID: 77951660671     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2008059     Document Type: Review

References (24)

1. Michie, H.R., Manogue, K.R., Spriggs, D.R., Revhaug, A., O'Dwyer, S., Dinarello, C.A., Cerami, A., Wolff, S.M., and Wilmore, D.W.: Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med., 318, 1481-1486, 1988.
2. Underhill, D.M. and Ozinsky, A.: Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol., 14, 103-110, 2002.
3. Karima, R., Matsumoto, S., Higashi, H., and Matsushima, K.: The molecular pathogenesis of endotoxic shock and organ failure. Mol. Med. Today, 5, 123-132, 1999.
4. Bhole, D. and Stahl, G.L.: Therapeutic potential of targeting the complement cascade in critical care medicine. Crit. Care. Med., 31, S97-104, 2003.
5. Hardaway, RM.: A review of septic shock. Am. Surg., 66, 22-29, 2000.
6. Esmon, C.T., Fukudome, K., Mather, T., Bode, W., Regan, L.M., Stearns-Kurosawa, D.J., and Kurosawa, S.: Inflammation, sepsis, and coagulation. Haematologica., 84, 254-259, 1999.
7. Weiss, S.J.: Tissue destruction by neutrophils. N. Engl. J. Med., 320, 365-376, 1989.
8. Chapman, H.A., Riese, R.J., and Shi, G.P.: Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol., 59, 63-88, 1997.
9. Deng, X., Wang, X., Lasson, A., Sun, T.Z., Soltesz, V., and Andersson, R.: The involvement of multiple protease-antiprotease systems and gut origin sepsis in zymosanassociated endothelial barrier injury and multiple organ dysfunction in rats. Shock, 16, 298-303, 2001. (Pubitemid 33599119)
10. Travis, J.: Structure, function, and control of neutrophil proteinases. Am. J. Med., 84, 37-42, 1988.
11. Tkalcevic, J., Novelli, M., Phylactides, M., Iredale, J.P., Segal, A.W., and Roes, J.: Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity, 12, 201-210, 2000. (Pubitemid 30398634)
12. Nakamura, A., Mori, Y., Hagiwara, K., Suzuki, T., Sakakibara, T., Kikuchi, T., Igarashi, T., Ebina, M., Abe, T., Miyazaki, J., Takai, T., and Nukiwa, T.: Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J. Exp. Med., 197, 669-674, 2003.
13. Fitzal, F., Delano, F.A., Young, C., Rosario, H.S., Junger, W.G., and Schmid-Schonbein, G.W.: Pancreatic enzymes sustain systemic inflammation after an initial endotoxin challenge. Surgery, 134, 446-456, 2003. (Pubitemid 37215150)
14. Pratt, C.W., Swaim, M.W., and Pizzo, S.V.: Inflammatory cells degrade inter-alpha inhibitor to liberate urinary proteinase inhibitors. J. Leukoc. Biol., 45, 1-9, 1989.
15. Gando, S. and Tedo, I.: Increased neutrophil elastase release in patients with cardiopulmonary arrest: role of elastase inhibitor. Intensive Care Med., 21, 636-640, 1995.
16. Ogawa, M., Nishibe, S., Mori, T., and Neumann, S.: Effect of human urinary trypsin inhibitor on granulocyte elastase activity. Res. Commun. Chem. Pathol. Pharmacol., 55, 271-274, 1987.
17. Ohwada, M., Watanabe, N., Maeda, M., Gotoh, M., Teramoto, J., Moriya, H., Nakajima, T., Okamoto, T., Tsuji, N., Kobayashi, D., and Niitsu, Y.: New endoscopic treatment for chronic pancreatitis, using contrast media containing ulinastatin and prednisolone. J. Gastroenterol., 32, 216-221, 1997.
18. Tani, T., Aoki, H., Yoshioka, T., Lin, K.J., and Kodama, M.: Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial. Crit. Care Med., 21, 925-930, 1993.
19. Masuda, T., Sato, K., Noda, C., Ikeda, K.M., Matsunaga, A., Ogura, M.N., Shimizu, K., Nagasawa, H., Matsuyama, N., and Izumi, T.: Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit. Care Med., 31, 1987-1992, 2003.
20. Sato, H., Kajikawa, S., Kuroda, S., Horisawa, Y., Nakamura, N., Kaga, N., Kakinuma, C., Kato, K., Morishita, H., Niwa, H., and Miyazaki, J.: Impaired fertility in female mice lacking urinary trypsin inhibitor. Biochem. Biophys. Res. Commun., 281, 1154-1160, 2001.
21. Cockcroft, D.W. and Davis, B.E.: Mechanisms of airway hyperresponsiveness. J. Allergy Clin. Immunol., 118, 551-559, 2006.
22. Inoue, K., Takano, H., Shimada, A., Yanagisawa, R., Sakurai, M., Yoshino, S., Sato, H., and Yoshikawa, T.: Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol. Pharmacol., 67, 673-680, 2005.
23. Inoue, K., Takano, H., Yanagisawa, R., Sakurai, M., Shimada, A., Yoshino, S., Sato, H., and Yoshikawa, T.: Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp. Biol. Med. (Maywood), 230, 281-287, 2005.
24. Inoue, K., Takano, H., Yanagisawa, R., Sakurai, M., Shimada, A., Sato, H., Kato, Y., and Yoshikawa, T.: Antioxidative role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Int. J. Mol. Med., 16, 1029-1033, 2005.